<qa>  What is the name of the subject who received anticancer therapy within 21 days prior to study2. Subjects who have received any anticancer therapy within 21 days prior to study entry for cytotoxic agents 42 days for mitomycin C and nitrosoureas, radiotherapy, hormonal, biological including humanized antibodies and targeted agents, or within 30 days for an investigational agent. 